SCHEMBL12450248

SCHEMBL12450248

CC1C(=O)CC(O)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14629087 1.00
SCHEMBL1709031 1.00
SCHEMBL1709034 1.00
SCHEMBL14226930 1.00
SCHEMBL12928668 1.00
SCHEMBL14629088 1.00
SCHEMBL12225583 1.00
SCHEMBL12928471 1.00
SCHEMBL27277795 0.77 CYP2D6 (0.34)
SCHEMBL24483924 0.75 CA1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104203887-B The manufacture method of triphen phenols 本州化学工业株式会社 2016-09-21 CN disclosed
CN-104203887-A Trisphenol production method HONSHU CHEMICAL IND 2014-12-10 CN disclosed
EP-1443938-B1 DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION SUCAMPO AG (CH) 2011-08-31 EP disclosed
EP-1857105-B1 Cathartic composition SUCAMPO AG (CH) 2010-08-11 EP disclosed
WO-2009005171-A1 PHARMACEUTICAL COMBINATION OF OPIOID AND PROSTAGLANDIN COMPOUND SUCAMPO AG (CH) 2009-01-08 WO disclosed
WO-2009005172-A1 PHARMACEUTICAL COMBINATION OF NSAID AND PROSTAGLANDIN COMPOUND SUCAMPO AG (CH) 2009-01-08 WO disclosed
EP-1315485-B1 CATHARTIC COMPOSITION SUCAMPO AG (CH) 2007-11-21 EP disclosed
EP-1857105-A2 Cathartic composition Sucampo AG (CH) 2007-11-21 EP disclosed